XLON
CNSL
Market cap5mUSD
Oct 13, Last price
1.75GBP
Name
Omega Diagnostics Group PLC
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Omega Diagnostics Group PLC is a company dedicated to the development, manufacturing, and global supply of medical diagnostic products. Its extensive market reach includes the United Kingdom, mainland Europe, North and South America, India, various East Asian nations, Africa, and the Middle East, with distribution to approximately 75 countries worldwide. The business is structured into two main operating divisions: Health and Nutrition, and Global Health and Other. The Health and Nutrition segment is responsible for the research, creation, and production of diagnostic kits, such as those under the Foodprint brand, which are designed to detect immune responses to different foods. This division also offers clinical analysis services to the general public, medical clinics, and healthcare practitioners, in addition to supplying the Food Detective, a consumer-grade food sensitivity test. The Global Health and Other segment focuses on the research, development, production, and commercialization of diagnostic tools for infectious diseases. Key offerings from this segment include VISITECT CD4, an advanced rapid diagnostic test for managing HIV patients, the AbC-19 kit for COVID-19 antibody detection, and other COVID-19 antigen and antibody testing solutions. Omega Diagnostics' diverse range of products is provided to hospitals, medical clinics, laboratories, and other healthcare professionals. The company was established in 1987 and is headquartered in Alva, United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||